On Friday, I-Mab ADR (NASDAQ: IMAB) was -4.07% drop from the session before settling in for the closing price of $1.23. A 52-week range for IMAB has been $0.99 – $2.54.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 935.64%. When this article was written, the company’s average yearly earnings per share was at 66.34%. With a float of $76.81 million, this company’s outstanding shares have now reached $77.02 million.
Considering the fact that the conglomerate employs 220 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 100.0%, operating margin of -9562.23%, and the pretax margin is -10168.55%.
I-Mab ADR (IMAB) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward I-Mab ADR stocks. The insider ownership of I-Mab ADR is 0.27%, while institutional ownership is 19.86%. The most recent insider transaction that took place on Jul 26 ’24, was worth 69,500.
I-Mab ADR (IMAB) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 66.34% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 26.00% during the next five years compared to -18.89% drop over the previous five years of trading.
I-Mab ADR (NASDAQ: IMAB) Trading Performance Indicators
You can see what I-Mab ADR (IMAB) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 16.50. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 82.62.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.55, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.61 in one year’s time.
Technical Analysis of I-Mab ADR (IMAB)
Compared to the last year’s volume of 0.34 million, its volume of 0.42 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 13.79%. Additionally, its Average True Range was 0.13.
During the past 100 days, I-Mab ADR’s (IMAB) raw stochastic average was set at 18.81%, which indicates a significant increase from 6.12% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 107.86% in the past 14 days, which was higher than the 75.44% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.2129, while its 200-day Moving Average is $1.5759. Nevertheless, the first resistance level for the watch stands at $1.2433 in the near term. At $1.3067, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.3533. If the price goes on to break the first support level at $1.1333, it is likely to go to the next support level at $1.0867. Now, if the price goes above the second support level, the third support stands at $1.0233.
I-Mab ADR (NASDAQ: IMAB) Key Stats
There are 80,883K outstanding shares of the company, which has a market capitalization of 90.88 million. As of now, sales total 3,890 K while income totals -206,440 K. Its latest quarter income was 0 K while its last quarter net income were 25,130 K.
